Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsFor over two decades, Creative Biolabs has stood at the forefront of antibody discovery, pioneering robust solutions for the global scientific community. Our Hybridoma Platform represents the gold standard in monoclonal antibody development, combining classic, Nobel Prize-winning technology with next-generation innovations. We deliver highly specific, stable, and scalable monoclonal antibodies tailored to your precise research, diagnostic, and preclinical needs. Partner with us to transform your scientific concepts into powerful biological tools.
While hybridoma technology is a well-established method, its success hinges entirely on execution. At Creative Biolabs, we have refined every step of the process to ensure unparalleled quality, speed, and success rates. Our platform is not just a service; it's a comprehensive ecosystem built on a foundation of deep immunological knowledge and cutting-edge technology.
We provide complete transparency throughout the development process. Our meticulously designed workflow ensures logical progression, frequent client updates, and superior outcomes.
Fig. 1 Workflow of the generation, screening, and characterization of the chimeric anti-PD-1 monoclonal antibodies.1
Our platform is modular, allowing you to select a full-package service or choose specific services to complement your in-house capabilities.
We offer tailored hybridoma development from a variety of species to suit your project's needs.
Creative Biolabs integrates your desired functional assay directly into our screening and selection workflow, ensuring that the clones we advance are not just binders, but performers. We de-risk your project by guaranteeing an antibody that works in your specific application. Our platform is equipped to screen for a wide range of functions. We collaborate with you to design a custom screening cascade to isolate antibodies with specific activities:
Our exclusive Hyperdoma™ Platform is designed for speed and scale. By combining optimized immunization with high-throughput screening, we can assess a vast number of clones to quickly identify rare antibodies with exceptional functional properties.
We offer flexible and scalable production options to provide you with the quantity and purity of antibody you need.
Table 1. Comparison of In Vitro and In Vivo Production Methods
| Feature | In Vitro Production (Cell Culture) | In Vivo Production (Ascites) |
| Purity | Very High (No host immunoglobulins) | Moderate (Contains host Ig) |
| Media | Serum-Free / Chemically Defined | Biological Fluid |
| Consistency | High Batch-to-Batch Consistency | Variable |
| Yield | 10-50 mg/L | 3-10 mg/mL (per mouse) |
| Best For | Therapeutic, Diagnostic, In Vitro Assays | High Concentration Needs, Some Assays |
| Ethics | Animal-Free Production Phase | Involves use of animals |
Hybridoma Sequencing
Protect your valuable research asset. We perform sequencing of the variable heavy (VH) and light (VL) chains of your hybridoma. This hybridoma sequencing technology provides:
Antibody Characterization and Validation
A great antibody is a well-characterized antibody. We offer a full suite of validation services:
Advanced Electrofusion Technology
We've moved beyond inconsistent PEG fusion. Our electrofusion platform provides precise, controlled, and highly efficient fusion of B cells and myeloma cells, resulting in a significantly higher number of stable, antibody-secreting hybridomas.
AI-Enhanced High-Throughput Screening
Our screening process is powered by automation and intelligent data analysis. By screening more clones with greater accuracy, we can identify high-affinity binders that traditional methods might miss, accelerating the path to your ideal candidate.
Optimized Immunization Strategies
We don't believe in a one-size-fits-all approach. Our scientists design bespoke immunization regimens, utilizing proprietary adjuvants and complex antigen presentation techniques (e.g., liposomes, cell-based immunization) to break tolerance and generate robust immune responses, even against challenging targets.
Antibodies developed on our Hybridoma Platform are trusted by researchers worldwide and are suitable for a vast range of applications:
Creative Biolabs offers a comprehensive suite of antibody discovery solutions. If the Hybridoma Platform doesn't fit your needs, explore our other world-class platforms:
Contact our team of experts today to discuss your project. Let us show you how our advanced single domain antibody discovery services can accelerate your research and development.
Q: What types of antigens can you work with?
A: We have extensive experience with a wide range of antigens, including recombinant proteins, peptides, whole cells, viruses, toxins, and small molecules (haptens). Please contact us to discuss your specific target.
Q: Why is hybridoma sequencing important?
A: Sequencing provides a permanent backup of your antibody, protecting against cell line instability, contamination, or loss. It is essential for intellectual property, long-term reproducibility, and enables recombinant antibody engineering.
Q: What is your success rate?
A: We are proud of our >95% success rate in generating antigen-specific monoclonal antibodies. Our project managers will work with you to define clear "success criteria" at the start of every project.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
